Pyridostigmine bromide
Pyridostigmine Bromide is a prescription drug that acts as a cholinesterase inhibitor, often used to treat muscle weakness in conditions like myasthenia gravis or as a protective agent against nerve agents. It comes in 30 mg oral tablets, manufactured by the US Army's Surgeon General department. This product is discontinued. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Pyridostigmine Bromide is a prescription drug that acts as a cholinesterase inhibitor, often used to treat muscle weakness in conditions like myasthenia gravis or as a protective agent against nerve agents. It comes in 30 mg oral tablets, manufactured by the US Army's Surgeon General department. This product is discontinued. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Pyridostigmine bromide",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Pyridostigmine bromide — ANDA 211694 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211694"
}
]
|
| identifier | ANDA211694 |
| issued | 2016-09-16 |
| keyword |
[
"drug-safety",
"health-care",
"pharmaceuticals",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Pyridostigmine bromide |
